SCHEMBL10883141

SCHEMBL10883141

CCc1cc(O)cc(CC)c1N=C1NCCN1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.31
PTPN11 Q06124 1/20 0.31
ESR1 P03372 1/20 0.30
ESR2 Q92731 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9616491 0.82 NOS3 (0.31)
Hydrochloric Acid SCHEMBL10879822 0.81 NOS3 (0.30)
SCHEMBL5154555 0.78 GABRA1 (0.46)
SCHEMBL9616494 0.77 HTT (0.49)
SCHEMBL11033315 0.77 POLB (0.42)
Hydrochloric Acid SCHEMBL10816153 0.77 LMNA (0.38)
SCHEMBL10877912 0.76 MEN1 (0.42)
SCHEMBL10875708 0.72 HSD17B10 (0.39)
SCHEMBL10879541 0.72 ALOX5 (0.34)
SCHEMBL10878917 0.70 RORC (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0081924-B1 TOPICAL COMPOSTIONS FOR LOWERING INTRAOCULAR PRESSURE ALCON LABORATORIES, INC. (US) 1986-02-19 EP disclosed
US-4517199-A TREATMENT OF GLAUCOMA ALCON LABORATORIES, INC. (US) 1985-05-14 US disclosed
US-4515800-A GLAUCOMA ALCON MANUFACTURING, LTD. 1985-05-07 US disclosed
EP-0081924-A1 Topical compostions for lowering intraocular pressure ALCON LABORATORIES, INC. (US) 1983-06-22 EP disclosed